Acetaminophen in aSAH to Inhibit Lipid Peroxidation and Cerebral Vasospasm
Public ClinicalTrials.gov record NCT00585559. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Inhibition of Lipid Peroxidation and Cerebral Vasospasm by an Acetaminophen-Based Regimen in Patients With Aneurysmal Subarachnoid Hemorrhage
Study identification
- NCT ID
- NCT00585559
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Vanderbilt University Medical Center
- Other
- Enrollment
- 44 participants
Conditions and interventions
Interventions
- Placebos for acetaminophen and N-acetylcysteine Drug
- APAP 1 gm every 6 hours and N-acetylcysteine placebo Drug
- NAC IV infusion at 0.5 gm hourly and APAP placebo Drug
- APAP 1 gm q6 hours, plus NAC IV infusion at 0.5 gm hourly Drug
- APAP 1.5 gm q6 hours, plus NAC IV infusion at 0.5 gm hourly Drug
Drug
Eligibility (public fields only)
- Age range
- 20 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2007
- Primary completion
- Oct 25, 2023
- Completion
- Oct 25, 2023
- Last update posted
- Apr 17, 2025
2007 – 2023
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00585559, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 17, 2025 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00585559 live on ClinicalTrials.gov.